Sign inJoin waitlistJoin the waitlist

Catherine Smith

Professor In Residence · University of California (San Francisco) School of Medicine

Credentials: · · ·

History

University of California (San Francisco) School of Medicine
Present

Hematology and Medical Oncology
University of California (San Francisco) School of Medicine
2005–2008
Internal Medicine
Brigham and Women's Hospital
2002–2005
Duke University School of Medicine
1998–2002
Yale University
1994–1998

Research

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
Nature · 2012 · First of 15 authors · 623 citations
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study
The Lancet Oncology · 2017 · 424 citations
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia
Cancer Discovery · 2019 · Co-senior of 21 authors · 371 citations

Neil Shah
22 papers
Alexander Perl
21 papers
Aaron Logan
14 papers
Cheryl Peretz
14 papers · 1 as a fellow
Rebecca Olin
14 papers
ML
Mark Levis
13 papers
ET
Elie Traer
10 papers
Vanessa Kennedy
10 papers · 4 as a fellow
Elliot Stieglitz
9 papers
Gary Schiller
9 papers
Maria Baer
9 papers
Jessica Altman
8 papers

Grants

Determining Biomarkers of Response and Resistance to Venetoclax and Azacitadine
National Cancer Institute · R01
Contact PI · $693.3K · University of California, San Francisco
2026–2031
Investigating the Mechanism of SHP2 and BCL2 Inhibition in Acute Myeloid Leukemia (AML)
National Cancer Institute · R01
Contact PI · $1.9M · University of California, San Francisco
2023–2028
RNA Polymerase II as a Therapeutic Target in Acute Myeloid Leukemia (AML) with RAS Signaling Activation
National Cancer Institute · R01
Contact PI · $2.9M · University of California, San Francisco
2022–2027
Investigating Resistance to FLT3 Inhibitors in AML
National Cancer Institute · K08
Contact PI · $703.2K · University of California, San Francisco
2014–2018